198 related articles for article (PubMed ID: 31523805)
21. Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.
Levin LI; Breen EC; Birmann BM; Batista JL; Magpantay LI; Li Y; Ambinder RF; Mueller NE; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1114-1123. PubMed ID: 28341757
[No Abstract] [Full Text] [Related]
22. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Slager SL; Benavente Y; Blair A; Vermeulen R; Cerhan JR; Costantini AS; Monnereau A; Nieters A; Clavel J; Call TG; Maynadié M; Lan Q; Clarke CA; Lightfoot T; Norman AD; Sampson JN; Casabonne D; Cocco P; de Sanjosé S
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):41-51. PubMed ID: 25174025
[TBL] [Abstract][Full Text] [Related]
23. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
24. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
Kok M; Bonfrer JM; Korse CM; de Jong D; Kersten MJ
Tumour Biol; 2003; 24(1):53-60. PubMed ID: 12743427
[TBL] [Abstract][Full Text] [Related]
25. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
Kara IO; Sahin B; Gunesacar R
Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
[TBL] [Abstract][Full Text] [Related]
26. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
[TBL] [Abstract][Full Text] [Related]
27. Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis.
Kara IO; Sahin B; Gunesacar R
Adv Ther; 2007; 24(1):29-40. PubMed ID: 17526459
[TBL] [Abstract][Full Text] [Related]
28. Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.
De Roos AJ; Mirick DK; Edlefsen KL; LaCroix AZ; Kopecky KJ; Madeleine MM; Magpantay L; Martínez-Maza O
Cancer Res; 2012 Sep; 72(18):4733-43. PubMed ID: 22846913
[TBL] [Abstract][Full Text] [Related]
29. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
[TBL] [Abstract][Full Text] [Related]
30. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.
Purdue MP; Lan Q; Kemp TJ; Hildesheim A; Weinstein SJ; Hofmann JN; Virtamo J; Albanes D; Pinto LA; Rothman N
Leukemia; 2015 Jun; 29(6):1429-31. PubMed ID: 25567136
[No Abstract] [Full Text] [Related]
32. Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies.
Kim C; Bassig BA; Seow WJ; Hu W; Purdue MP; Huang WY; Liu CS; Cheng WL; Männistö S; Vermeulen R; Weinstein SJ; Lim U; Hosgood HD; Bonner MR; Caporaso NE; Albanes D; Lan Q; Rothman N
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):148-53. PubMed ID: 25293880
[TBL] [Abstract][Full Text] [Related]
33. Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases.
Jelloul FZ; Chen QH; Yang T; Haghi N; Brody J; Zhang X; Sheikh-Fayyaz S
Int J Surg Pathol; 2018 Apr; 26(2):135-144. PubMed ID: 29069998
[TBL] [Abstract][Full Text] [Related]
34. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
35. Fruits and vegetables consumption and risk of non-Hodgkin's lymphoma: a meta-analysis of observational studies.
Chen GC; Lv DB; Pang Z; Liu QF
Int J Cancer; 2013 Jul; 133(1):190-200. PubMed ID: 23238796
[TBL] [Abstract][Full Text] [Related]
36. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph [correction of IinterLlymph] analysis.
Cocco P; Vermeulen R; Flore V; Nonne T; Campagna M; Purdue M; Blair A; Monnereau A; Orsi L; Clavel J; Becker N; de Sanjosé S; Foretova L; Staines A; Maynadié M; Nieters A; Miligi L; 't Mannetje A; Kricker A; Brennan P; Boffetta P; Lan Q; Rothman N
Occup Environ Med; 2013 Nov; 70(11):795-802. PubMed ID: 23881218
[TBL] [Abstract][Full Text] [Related]
37. Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.
Takemoto S; Iwanaga M; Sagara Y; Watanabe T
Asian Pac J Cancer Prev; 2015; 16(18):8253-8. PubMed ID: 26745069
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
[TBL] [Abstract][Full Text] [Related]
39. Circulating soluble CD30 and future risk of lymphoma; evidence from two prospective studies in the general population.
Vermeulen R; Hosnijeh FS; Portengen L; Krogh V; Palli D; Panico S; Tumino R; Sacredote C; Purdue M; Lan Q; Rothman N; Vineis P
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1925-7. PubMed ID: 21784955
[TBL] [Abstract][Full Text] [Related]
40. Body mass index and survival of patients with lymphoma.
Chihara D; Larson MC; Robinson DP; Thompson CA; Maurer MJ; Casulo C; Pophali P; Link BK; Habermann TM; Feldman AL; Flowers CR; Cerhan JR; Morton LM
Leuk Lymphoma; 2021 Nov; 62(11):2671-2678. PubMed ID: 34121594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
